chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Episode of seizures, 10 days, post vax. Also had a fever. Was flown to the hospital on a ventilator at this time.
Injection site pain. Narrative: Injection site pain "it was severe". "I cannot move my arm and cannot stand the pain". "Due to the pain I stayed home and slept for 10 hours." "I slept so I cannot feel the pain. "I feel better at 5 pm yesterday". Resulted in unable to work 2/2/2021.
Information has been received from a healthcare worker referring to unspecified patients of unknown age and gender. No information about medical history, concurrent conditions were reported for the patients. On unknown dates, the patients were administered with unknown number of doses of improperly stored PNEUMOVAX23 (dose strength, route, lot # unspecified). No adverse effects reported. This is one of the several reports received from the same source.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 26-Mar-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 26-Mar-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 26-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 26-Mar-2022) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2022 at 1:07 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 26-Mar-2022 at 1:07 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 26-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 26-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 26-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 26-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug information was provided.  Patient received booster dose.  The 30 days Expiry date vaccine went into 2 to 8 °C thaw state on or about to 20-Dec-2021, this vaccine administered until its Mfg date of 04-Apr-2022  No treatment drug information was received.   This case was linked to MOD-2022-542869 (Patient Link).
Client received vaccine on 1/14/2021. Started noticing generalized itching on 1/23/2021, on Monday 1/5/2021 arm where received vaccine was red, firm and warm to touch Client went to md office for eval and was advised not to get the second dose
Covid- 19 vaccine 5-11 was given to a 12 year old Patient. Patient was observed for 15 minutes, patient had no reaction. Mom is aware of the situation. Advised mom that we will contact her on what will happen with 2nd dose.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 18Sep2023 at 16:00 as dose 7 (booster), single (Batch/Lot number: unknown) at the age of 40 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Crohn's" (unspecified if ongoing); "Diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Quinolone antibiotics, reaction(s): "Known allergies: quinolone antibiotics". Vaccination history included: Covid-19 vaccine (Dose 1; Manufacturer Unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 2; Manufacturer Unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER); Manufacturer Unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE 4 (BOOSTER); Manufacturer Unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE 5 (BOOSTER); Manufacturer Unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE 6 (BOOSTER); Manufacturer Unknown), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (Oct2023) Positive, notes: Rebound COVID symptoms and positive testing. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.  Clinical course: The patient tested positive for covid-19 on an unspecified date. He was treated with PAXLOVID from 26Sep2023 to 30Sep2023 He later experienced Rebound COVID symptoms and positive testing, mild so far, rebound symptoms began four days after final PAXLOVID dose (04Oct2023).  The information on the batch/lot number for [BNT162B2 OMI XBB.1.5] has been requested and will be submitted if and when received.; Sender's Comments:  ~~~
had an area of red, hot swollen indurated area that was far away an inch from the vaccine/very painful, very swollen, red, hot and indurated so hard; had an area of red, hot swollen indurated area that was far away an inch from the vaccine/very painful, very swollen, red, hot and indurated so hard; had an area of red, hot swollen indurated area that was far away an inch from the vaccine/very painful, very swollen, red, hot and indurated so hard; had an area of red, hot swollen indurated area that was far away an inch from the vaccine/very painful, very swollen, red, hot and indurated so hard; had an area of red, hot swollen indurated area that was far away an inch from the vaccine/very painful, very swollen, red, hot and indurated so hard; It continued to get worse over the next 24 hours; it continued to get worse after that it peak about 72 hours so enlarged in size; This is a spontaneous report from a contactable physician (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown, expiry date 31Mar2021), via an unspecified route of administration on 05Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Physician stated, "I just want to check actually because just before I waited should l be reporting an adverse reaction from the COVID vaccine. Should I be doing that online or over the phone? So I had the injection two weeks ago actually it was the day, I had it on 05Jan2021. So within 24 hours after I had the vaccine, I had an area of red, hot swollen indurated area that was far away an inch from the vaccine. It is not like within an inch the injection place and then it continued to get worse over the next 24 hours and then it continued to get worse after that it peak about 72 hours so enlarged in size so I would say the area of redness it was well I marked it. It was like about almost three inches by 3 inches.  So it continued to grow to that size like I said peak about 72 hours and very painful, very swollen, red, hot and indurated so hard so then it started to decrease from there. Still quite painful and finally I would say now two weeks after, the pain is gone and the redness is gone so it is now resolved." Clinical outcome of the events was recovered on Jan2021.  Information on the lot/batch number has been requested.
4/24 or 04/25 started fever, had 2-3 days, very sleepy, 4/24 blister on right wrist, 2 on chest, 1 on back, 3-4 arms, 3-4 legs. The DR who saw her is family friend but said is definite varicella (is a pediatrician).
Left injection site arm hurts; slight fever; sore left arm/arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm/arm hurts), PYREXIA (slight fever) and VACCINATION SITE PAIN (Left injection site arm hurts) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0021424A, 939905, 010A21A and 3032264) for COVID-19 prophylaxis.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (sore left arm/arm hurts). In March 2021, the patient experienced PYREXIA (slight fever). In November 2021, the patient experienced VACCINATION SITE PAIN (Left injection site arm hurts). At the time of the report, PAIN IN EXTREMITY (sore left arm/arm hurts), PYREXIA (slight fever) and VACCINATION SITE PAIN (Left injection site arm hurts) outcome was unknown.            Concomitant medications were not reported.   Treatment medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-744784 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-744784:Bivalent Case
SMALL BLOOD BLISTER; This spontaneous case report was received from a caregiver (PVX2019-114) on 11-Jan-2019. The report describes a male consumer who developed small blood blister following the intake of oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  It was reported that the consumer took the first dose of Vivotif on Wednesday (09-Jan-2019) and today morning he had a small blood blister, but it's flat, right where his bottom lip and his skin meet. The consumer did not experience any other adverse effects such as swelling lethargy, he was not tired and totally fine. However, when he came home from work today, he noticed a second blister.  The action taken with Vivotif with respect to the event small blood blister was unknown.  The clinical outcome of the event small blood blister was unknown.  Company's Comment: In this case, a male consumer developed small blood blister following the intake of oral Vivotif. Although, the events were reported with reasonable time relationship to intake of the vaccine, there is limited information regarding the medical history, concomitant medications and events in this case. Therefore, the causality of the event "small blood blister" with Vivotif could not be assessed.; Sender's Comments: Company's Comment: In this case,a male consumer developed small blood blister following the intake of oral Vivotif.Although, the events were reported with reasonable time relationship to intake of the vaccine, there is limited information regarding the medical history, concomitant medications and events in this case. Therefore, the causality of the event "small blood blister" with Vivotif could not be assessed.
When I woke up on 12/09/2022, I had a scratchy throat and runny nose with postnasal drip. Those symptoms got worse over the day and progressed into a sore throat. I also began to have body aches that night. I tested myself for COVID-19 that night and it was positive. The next morning, I had severe body aches all over but especially in my back. Everything hurt, but my back was the worst. My voice was also scratchy. I was congested and my head hurt worse than a normal headache. On the left side, it felt like something was packed in the side of my head. My left eye also hurt. My other symptoms persisted, and I had a lot of chills and my body temperature alternated from hot to cold. I was also extremely tired and developed stomach cramps. My symptoms continued into Sunday but changed slightly. I didn't have any chills or body aches and my headache went away. I also developed nausea and would become slightly dizzy when I would try to move around the house. On Monday morning, I called my doctor's office. They eventually got back to me later that evening. I asked him about treatment options. I live with my mother who is elderly and high risk, so I was concerned about her contracting this as well. They called in a prescription of PAXLOVID for me, and I was able to get that and began taking it the next day, on 12/13/2022. I had been napping multiple times a day since Saturday. Today, I feel better. I am not nauseous but I my chills have returned. I am still tired, but not as bad and I haven't had to nap today.
Td administered to patient. Less than 3 minutes later patient was leaving clinic and collapsed to floor. He did not have any trauma. He was cold and sweating. He was unresponsive for 10 seconds but quickly woke up and was aware of his surroundings. A damp cloth was applied to his forehead. After 3 minutes he was move to a nearby chair. 30 seconds later he again became unresponsive. I could not find a pulse for 20 seconds. His eye deviated upward. EMS was called. He woke up again and was aware of his surroundings with a normal puse and respirations. EMS took him to hospital. The work-up was normal and he was diagnosed with a vagal response. The patient returned to clinic 4 hours after leaving and appeared normal.
Pt had no symptoms, wrong vaccine given. Pt received Tdap instead of 5th DTaP. No reaction.
This medically confirmed spontaneous report (initial receipt: 26-Feb-2016) concerns a 46 year-old male patient. On 09-Sep-2015, the patient received AFLURIA (batch number U55406; expiry date: 30-Jun-2016 yet reported as 12-Jun-2016). The AFLURIA vaccine was stored at 0.6 to 1.1 degrees Celsius (reported as 33-34 degrees Fahrenheit) multiple times. The last excursion was 0 degrees Celsius (reported as 32 degrees Fahrenheit) for no more than 24 hours. The outcome was not reported.
During Covid-19 facility audit by DOH, it was brought to our attention this individual was not of the recommended age to receive this vaccine.
Constant global inflammation. Itchy rash on face, neck, chest, back, and often arms and legs that looks similar to acne but is extremely itchy. Began shortly after receiving the vaccine. I'm constantly in a state of inflammation now, almost like I'm constantly having a mild to moderate allergic reaction to something. It's gotten worse over time now to where I'm constantly itching and "breaking out" and now no medication or creams are helping. I now have scars and skin discoloration from the rash.
Post vaccination client c/o itchiness that started around the site, around face and neck.  No swelling noted to site face or neck.  Vital signs x2, water and ice pack provided, and Benadryl given.  Client preferred the children's dose.  Administered per standing order of 2x12.5mg PO chewable. After 15 mins client stated it was not progress but itchiness still present.  Extended observation time for another 15mins. Client left site accompanied by 2 people.  Nurse hotline called and informed of incident.
This case was reported by a consumer via call center representative and described the occurrence of injection site muscle pain in a 40-year-old male patient who received FLUARIX. In October 2015, the patient received FLUARIX. In October 2015, less than a day after receiving FLUARIX, the patient experienced injection site muscle pain and injection site discomfort. On an unknown date, the outcome of the injection site muscle pain and injection site discomfort were not recovered/not resolved. The reporter considered the injection site muscle pain and injection site discomfort to be probably related to FLUARIX. Additional details were provided as follows: This case was not previously reported to anyone. Sometime in early to mid of October 2015, the patient received the FLUARIX vaccine in his left arm at work for a routine vaccination. In October 2015, less than a day after receiving the vaccine, the patient experienced a muscular type ache in the arm at the injection site, which has continued till the time of reporting. The patient's arm hurts on moving and he had not experienced anything like this from previous flu vaccinations. In October 2015, less than a month after receiving the vaccine, the patient experienced mild discomfort until about three days before the time of reporting, when he woke up and noticed the discomfort in his arm had increased. He initially thought that he had slept on it wrong and stated that it feels like a band around his arm at the area of the injection site. However, the discomfort has continued and was only a little better at the time of reporting. The reporter wanted to be contacted as soon as possible because he was concerned that the events could progress into something worse. The patient wanted to know if the events were common to experiences for almost 3 months and inquired solution for the discomfort.
swollen lymph nodes under her right arm; chills/Cold Chills; sore back/Back was hurting; sore arm/arm was sore and really hurting; This is a spontaneous report received from a contactable consumer(patient). A 53-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, Formulation: solution for injection, Lot Number: EW0161, Expiry date: unknown), via an unspecified route of administration on 10Apr2021 at 09:00, as single dose for covid-19 immunisation. The patient medical history included first dose of bnt162b2 (Lot number: ER2613) received on 20Mar2021. On 20Mar2021, the patient Arm hurt bad, like really achy. The event recovered on 22Mar2021. Concomitant medication included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. Prior Vaccinations (within 4 weeks), Patient has had both doses of the Pfizer Covid Vaccine. On 11Apr2021, the patient experienced chills/cold chills, sore back/back was hurting, sore arm/arm was sore and really hurting, swollen lymph nodes under her right arm on 12Apr2021. She wanted to know if that was a side effect, what should she take, how long will that last, and is this normal. Caller clarifies that with the first one, her arm hurt bad, like achy. She never checked her lymph nodes then. The events were considered as non-serious. The outcome of the event was chills/cold chills reported as recovered on 12Apr2021 and other events were reported as recovering.
pt recv vax & approx 12 days later 29MAR98 pt devel a deep vein thrombosis;hosp for 11 days @ the end of MAR98 & tx w/coumadin;
12/06-1/12/07 abdominal pain, nausea, vomiting. 1/15/07 upper GI. 3/15/07 GARDASIL #1. 3/20/07 unknown rash. 5/7/07 GARDASIL #2. 5/26/07 unknown rash. 9/14/07 GARDASIL #3. 9/24/07 unknown rash. 11/27/07 unknown rash. 2/20/08 ATTACK...left optic neuropathy, treated with prednisone over several days. Test positive for NMO IgG. 2/28/08 MRI Brain scan to determine damage to optic nerve. 3/1/08-5/18/08 prednisone treatment plan. 3/27/08 diagnosis of NMO from clinic. Discussed treatment with RITIXIMAB. 4/10/08 MRI thoracic spine, lesion discovered. 4/14/08 chest x ray. 5/16/08 leg pain, numbness. 5/20/08 hospital visit confirm diagnosis of NMO. 6/15/08-6/17/08 ATTACK...back pain/numbness in right leg/stomach numbness. 6/18/08 MRI thoracic spinal lesion confirmed. 6/18-6/22 Infusion SOLU-MEDROL 1000 mg (home). 6/22/08 ATTACK..back pain/numbness right leg/stomach numbness. 6/23/08-8/9/08 MEDROL tablet started. 7/14/08 MRI thoracic (follow up). 7/16 Infusion SOLU-MEDROL 1000 mg (hospital). 7/30/08 Infusion SOLU-MEDROL 1000 mg (hospital). 8/20/08 back pain. 8/20/08 MRI thoracic lesion noted. 10/3/08 back pain. 10/6/08 ATTACK...back pain. 10/7/08 back pain. 10/7/08-10/11/08 Infusion SOLU-MEDROL 1000mg (hospital). 10/27/08 mild back pain. 10/27/08 Infusion SOLU-MEDROL 1000mg (home). The medical team's initial evaluation, at this time, leads them to believe than the GARDASIL vaccine was the "trigger" that caused the NMO to surface. 11/24/08-records received-Neurology consult 6/20/08-3-5 episodes nausea and vomiting December 2006, symptoms resolved. Rashes after 3 Gardasil vaccinations. In February while on vacation in Mexico developed pain and decreased vision in left eye. MRI demonstrated enhancing lesion in left optic nerve, neuraxis. DX neuromyelitis optica. Three weeks ago intermittent episodes low back pain and hospitalized for severe impaction. Now C/O recurrence of back pain and numbness below waist. C/O numbness in both lower extremities left greater than right.  1/28/2010 Diagnosed with Neuromyelitis Optica (NMO) and continues to have attacks which leave spinal lesions in place. On combination of drugs to mitigate attacks.
Sharp pain at injection site intermittently reoccurs . Upper arm sore for several months, especially near injection site, but pain feels sharp and deep. Specific movements are still painful a year later. Raising my arm laterally or laterally and towards the back sends a sharp shooting pain through my deltoid.
Patient presented with redness and swelling from shoulder down past elbow. Significant swelling just below elbow.
Systemic: Fainting / Unresponsive-Severe, Additional Details: patient unresponsive while very stiff for several minutes. has happened before with bloodwork.
A mother reported, via a company representative, that her 4.5 year old daughter received an initial dose of Prevnar vaccine in DEC-2000. In DEC-2000, she developed wheezing and coughing. In JAN-2001, the child developed a "barking" cough that did not resolve for months. The child has also been on antibiotics every month since receiving Prevnar for ear infections. The HCP told the mother that the child's lungs were clear. In APR-2001, the child developed bilateral ear infections, cough and was diagnosed with pneumonia. The child developed a fever of 104 degrees, of 6 days duration. After 2 days of fever, was treated with Zithromax with no resolution of fever. The child developed "violent" vomiting for 3 days and then developed "severe" diarrhea. The fever was treated with Tylenol or Advil and it resolved. No additional information was available as of this report. Follow up information received 7 JUL 2001, stated that child had several ER visits. Additional information received 7 SEP 2001, stated that the child was given a diagnosis of asthma in July 2001.
Tested PCR (+) via nasal swab for Pertussis. Onset of cough 3/9/2012. Pt. not hospitalized. Treated with Z-PACK x 5 days.